SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-23-004875
Filing Date
2023-01-09
Accepted
2023-01-09 17:28:34
Documents
72
Period of Report
2022-11-30

Document Format Files

Seq Description Document Type Size
1 10-Q d431451d10q.htm   iXBRL 10-Q 1483959
2 EX-31.1 d431451dex311.htm EX-31.1 11004
3 EX-31.2 d431451dex312.htm EX-31.2 11084
4 EX-32 d431451dex32.htm EX-32 6228
  Complete submission text file 0001193125-23-004875.txt   7650948

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA neog-20221130.xsd EX-101.SCH 47047
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE neog-20221130_cal.xml EX-101.CAL 53867
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE neog-20221130_def.xml EX-101.DEF 387548
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE neog-20221130_lab.xml EX-101.LAB 448825
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE neog-20221130_pre.xml EX-101.PRE 431686
66 EXTRACTED XBRL INSTANCE DOCUMENT d431451d10q_htm.xml XML 1318563
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

IRS No.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 000-17988 | Film No.: 23519018
SIC: 2835 In Vitro & In Vivo Diagnostic Substances